• Dietary intake of acrylamide and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort 

      Obon-Santacana, M; Kaaks, R; Slimani, N; Lujan-Barroso, L; Freisling, H; Ferrari, P; Dossus, L; Chabbert-Buffet, N; Baglietto, L; Fortner, RT; Boeing, H; Tjønneland, A; Olsen, A; Overvad, K; Menéndez, V; Molina-Montes, E; Larrañaga, N; Chirlaque, MD; Ardanaz, E; Khaw, KT; Wareham, N; Travis, RC; Lu, Y; Merritt, MA; Trichopoulou, A; Benetou, V; Trichopoulos, D; Saieva, C; Sieri, S; Tumino, R; Sacerdote, C; Galasso, R; Bueno-De-Mesquita, HB; Wirfält, E; Ericson, U; Idahl, A; Ohlson, N; Skeie, Guri; Gram, Inger Torhild; Weiderpass, Elisabete; Onland-Moret, NC; Riboli, E; Duell, EJ (Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
    • Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study 

      Zamora-Ros, R; Sacerdote, C; Ricceri, F; Weiderpass, Elisabete; Roswall, N; Buckland, G; St-Jules, DE; Overvad, K; Kyrø, C; Fagherazzi, G; Kvaskoff, M; Severi, G; Chang-Claude, J; Kaaks, R; Nöthlings, U; Trichopoulou, A; Naska, A; Trichopoulos, D; Palli, D; Grioni, S; Mattiello, A; Tumino, R; Gram, Inger Torhild; Engeset, Dagrun; Huerta, JM; Molina-Montes, E; Argüelles, M; Amiano, P; Ardanaz, E; Ericson, U; Lindkvist, B; Nilsson, LM; Kiemeney, L; Ros, M; Bueno-de-Mesquita, HB; Peeters, PHM; Khaw, KT; Wareham, NJ; Knaze, V; Romieu, I; Scalbert, A.; Brennan, P; Wark, P; Vineis, P; Riboli, E; González, CA (Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
    • The INSIG2 rs7566605 polymorphism is not associated with body mass index and breast cancer risk 

      Campa, D; Lund, Eiliv; Husing, A; McKay, JD; Sinilnikova, OM; Vogel, U; Tjonneland, A; Overvad, K; Stegger, J; Clavel-Chapelon, F; Chabbert-Buffet, N; Fagherazzi, G; Trichopoulou, A; Zylis, D; Oustoglou, E; Rohrmann, S; Teucher, B; Fisher, E; Boeing, H; Masala, G; Krogh, V; Sacerdote, C; Panico, S; Tumino, R; Onland-Moret, NC; van Gils, CH; Bueno-de-Mesquita, H. Bas; Chirlaque, MD; Sala, Núria; Quiros, JR; Ardanaz, E; Amiano, P; Molina-Montes, E; Hallmans, G; Lenner, P; Travis, R; Key, TJ; Wareham, N; Khaw, KT; Rinaldi, S; Slimani, N; Chajes, V; Siddiq, A; Riboli, E; Kaaks, R; Canzian, F (Journal article; Tidsskriftartikkel; Peer reviewed, 2010)
    • Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition 

      Tsilidis, KK; Allen, Naomi; Key, TJ; Dossus, L; Lukanova, A; Bakken, Kjersti; Lund, Eiliv; Fournier, Agnes; Overvad, Kim; Hansen, L; Tjønneland, Anne; Fedirko, V; Rinaldi, S; Romieu, I; Clavel-Chapelon, Francoise; Engel, P; Kaaks, R; Schütze, M; Steffen, A; Bamia, C; Trichopoulou, A; Zylis, D; Masala, G; Pala, V; Galasso, R; Tumino, R; Sacerdote, C; Bueno-De-Mesquita, HB; van Duijnhoven, FJB; Braem, MGM; Onland-Moret, NC; Gram, Inger Torhild; Rodriguez, L; Travier, N; Sánchez, M-J; Huerta, JM; Ardanaz, Eva; Larrañaga, N; Jirstrom, K; Manjer, J; Idahl, A; Ohlson, N; Khaw, KT; Wareham, N; Mouw, T; Norat, T; Riboli, Elio (Journal article; Tidsskriftartikkel; Peer reviewed, 2011-09-03)
      BACKGROUND: It is well established that parity and use of oral contraceptives reduce the risk of ovarian cancer, but the associations with other reproductive variables are less clear.<p> <p>METHODS: We examined the associations of oral contraceptive use and reproductive factors with ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Among 327 396 eligible ...